Paan/MIF nuclease inhibition for neuroprotection in multiple sclerosis
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210819
- Recipient
-
The Johns Hopkins University UEI FTMTDMBR29C7
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $980,943
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Baltimore, MD 21218, USA
Award details come from USAspending.gov.
About this award
The Johns Hopkins University was awarded a $980,943 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research into PAAN/MIF nuclease inhibition for neuroprotection in multiple sclerosis from August 15, 2022 to August 14, 2025.
The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care through innovative research and investigating medical solutions for battlefield medicine. This award will allow The Johns Hopkins University to investigate using PAAN/MIF nuclease inhibition for neuroprotection in patients with multiple sclerosis, advancing the program's goals of developing medical solutions and transforming health care.
Quick answers
Who received award W81XWH2210819?
W81XWH2210819 was awarded to The Johns Hopkins University by Medical Command (Department of the Army) on August 15, 2022.
How much is award W81XWH2210819 worth?
$980,943 has been obligated on W81XWH2210819.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award